Recently, we described the cloning and genomic structure of the transforming acidic coiled coil 2 gene (TACC2) (Lauffart et al., 2003) , a member of the evolutionarily conserved TACC family of genes (Still et al., 1999a) . These genes encode proteins that are highly acidic and contain a conserved 200 amino-acid coiled coil domain, termed 'the TACC domain', which we previously predicted to play a critical role in the function of these proteins (Still et al., 1999a) . Both in vitro and in vivo studies indicate that the TACC proteins are functionally linked to the processes of cell growth and differentiation (Gergely et al., 2000; Lauffart et al., 2003; Sadek et al., 2003) . In fact, functional deletion of the Tacc3 gene in mice is embryonically lethal, with homozygous knockout mice dying during mid to late gestation (Piekorz et al., 2002) . At present, however, evidence indicates a contrasting role for the TACC family in processes underlying the development of cancer. On the one hand, the expression of specific TACC1 isoforms has been implicated in the development of gastric cancer (Line et al., 2002) . On the other, the TACC1 protein has been shown to be significantly reduced in 50% of resected breast tumors, compared to normal levels, suggesting that TACC1 may be a breast tumor suppressor gene (Conte et al., 2002 (Conte et al., , 2003 . TACC2 has also been suggested to be a candidate tumor suppressor gene (Chen et al., 2000; Conte et al., 2003; Lauffart et al., 2003) . Overexpression of the short isoform, TACC2s, can reduce the in vitro tumorigenic properties of estrogen receptor negative breast cancer cell lines (Lauffart et al., 2003) ; an effect that is apparently mediated by the conserved TACC domain (Chen et al., 2000; Still et al., unpublished) .
It is known that all the TACC proteins identified to date interact via the TACC domain with the microtubule-binding proteins of the stu2/msps/ch-tog family, and the Aurora Kinases, and that these interactions are required for the accumulation of ce-TAC-1, D-TACC and the vertebrate TACC3 proteins to the centrosome (Lee et al., 2001; Giet et al., 2002; Le Bot et al., 2003; Srayko et al., 2003; Tien et al., 2003) . However, although initially described as centrosomal proteins (Gergely et al., 2000; Gergely, 2002) , during interphase the human TACC proteins are actually distributed throughout the cell, with TACC1 and TACC3 being primarily concentrated in the nucleus (Gergely et al., 2000) . Nuclear accumulation of TACC3 has also been noted during normal mouse development (Aitola et al., 2003; Sadek et al., 2003) . Thus, the distribution and behavior of the TACC proteins resembles those of signaling intermediates that shuttle between the cytoplasm and the nucleus, suggesting that TACC proteins may have additional functions outside their potential role at the centrosome and during mitosis. Indeed, TACC2 has been shown to migrate to the nucleus upon stimulation of microvascular endothelial cells with erythropoietin, implicating TACC2 in erythropoietin signaling (Pu et al., 2001) . Furthermore, we have recently demonstrated that human TACC1 and TACC2 interact with the potential nuclear oncogene, glioma amplified sequence 41 (GAS41) (Lauffart et al., 2002 (Lauffart et al., , 2003 and that TACC2s is found in a complex with the INI-1 core component of the SWI/SNF complex, presumably through its interaction with GAS41 (Lauffart et al., 2003) . Mouse Tacc3 can coactivate the transcriptional response to hypoxia, by binding to the arylhydrocarbon nuclear translocator (ARNT1) transcription factor (Sadek et al., 2000) , directly implicating a TACC family member in transcriptional control. We now present further evidence for an intimate role for the TACC proteins in transcription by describing their physical association with the histone acetyltransferase (HAT) family of transcriptional coactivators. This raises the possibility that aberrant expression of one or more TACC proteins may affect gene regulation through their interaction with components of chromatin remodeling complexes, thus contributing to tumorigenesis.
To further clarify the potential function of the TACC proteins in the interphase cell, we have initiated a yeast two-hybrid based screen to identify proteins that interact with the conserved TACC domain of TACC2s. We fused the TACC2s open reading frame from amino acid (aa) 767-1094 to the GAL4 DNA-binding domain of the pAS2.1 vector. This construct was transformed into CG1945, and lack of autoactivation and lack of nonspecific interactions confirmed between the bait TACC2 protein and the GAL4 activation domain and human lamininC negative control proteins. The TACC2 bait was then used to screen a fetal brain cDNA library (BD Biosciences Clontech), as previously described (Lauffart et al., 2002) . Approximately 10 6 transformants were plated and selected on His À selective media containing 10 mM 3-aminotriazole. Of the 30 His þ clones initially isolated, six proved positive when assayed for b-galactosidase activity using the colony lift assay. The numbers of clones isolated during this procedure were comparable to other published manuscripts, including those on TACC proteins (Conte et al., 2002; Lauffart et al., 2002) , suggesting that these clones represented bona fide TACC2 interacting partners. Subsequent isolation and sequence analysis revealed that one of these clones, FB6, corresponded to the carboxy terminal 215 aa's of the HAT hGCN5L2 ( Figure 1a ). This region contains the bromodomain (BrD), which has been identified in several transcriptional regulatory proteins, and the ADA2 interaction region (Xu et al., 1998) (Figure 1a ). To confirm that the interaction between hGCN5L2 and TACC2s is direct, and to further refine the binding site of TACC2s on hGCN5L2, we next assessed this novel interaction using the glutathione-S-transferase (GST) pull-down assay. Deletion and smaller fragments of hGCN5L2 were cloned in pET28c and tested for their ability to interact with TACC2s. TACC2s was expressed in E. coli as a GST fusion protein, incubated with each in vitro translated hGCN5L2 subfragment, and subjected to several wash steps to remove any nonspecific binding. As can be seen in Figure 1b , TACC2s was found to bind specifically to the ADA2 interaction region, but was unable to interact with the BrD, when this region was expressed separately. Thus, the interaction of TACC2 with the yeast two-hybrid clone FB6 was due to the specific binding of the coiled coil domain of TACC2 to the ADA2 interacting domain contained within this clone. In addition, a second TACC2-binding domain in hGCN5L2 was also detected: TACC2s interacted with those constructs that contained the intact HAT domain, and bound weakly to construct 8, which contained the N-terminal section of the HAT domain. Lack of binding to aa 360-471 further suggested that TACC2 specifically binds to the ADA2 interaction domain and the intact HAT catalytic domain of hGCN5L2.
The TACC family of proteins is defined by a highly conserved C-terminal 200 aa coiled coil domain (TACC domain) (Still et al., 1999a, b) . The TACC domain of TACC2 shows highest homology to that of TACC1 Interaction of TACC2 with hGCN5L2 constructs by GST pull-down. Lane numbering corresponds to the numbered hGCN5L2 construct in (a). Top panel: Autoradiograph of 12% SDS polyacrylamide gels with in vitro translated hGCN5L2 construct pulled down with GSTTACC2s (T) or GST (G). I: 5% input of hGCN5L2 construct; bottom two panels represent Coomassie blue stained gels of the pull-down experiment, verifying equal loading of the GST fusion proteins. Full-length TACC2s was cloned into pGEX5X2 (Amersham Biosciences, Piscataway, NJ, USA), and GST-fusion protein prepared and immobilized on glutathione sepharose beads, as previously described (Lauffart et al., 2003) . Subclones of hGCN5L2 were generated by PCR (primers sequences available on request) and cloned into pET28c (Novagen, Madison WI, USA). These constructs were used to synthesize 35 S-radiolabeled proteins by the TNT quick coupled transcription/translation system kit (Promega, Madison WI, USA), according to the manufacturer's instructions. In total, 5 mg of immobilized GST protein was incubated with 60% of the in vitro translated protein in HEPES binding buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 12% glycerol and protease inhibitors) at 41C for 90 min. Unbound labeled protein was removed by washing four times with binding buffer. Bound proteins were then eluted by boiling in GST elution buffer (100 mM Tris-HCl, pH 8.0, 20 mM reduced glutathione) and analysed on 12% SDS polyacrylamide gels. Dried gels were autoradiographed TACC interaction with histone acetyltransferases O Gangisetty et al (74% identity) (Still et al., 1999a) . Thus, the finding that this region of TACC2 binds to hGCN5L2 suggested that the other TACC family members could also bind to this HAT. To address this issue, TACC1 (aa596-ter) and TACC3 (aa116-ter) were fused to GST and assayed for binding to in vitro synthesized hGCN5L2, as described above. Figure 2 shows that both these proteins bind directly to the hGCN5L2 protein, confirming that the TACC proteins, as a whole, are a family of hGCN5L2-binding proteins.
Given that the TACC2s-binding site on hGCN5L2 is highly related to pCAF (79% identity), it would seem likely that TACC2s could also interact with pCAF. Furthermore, previously, Yang et al. (1996) demonstrated that pCAF and hGCN5L2 form complexes with two other highly related HATs, that is, the CREBbinding protein (CBP) and p300, and different combinatorial interactions between these proteins can govern the transcriptional activation of a number of promoters by specific transactivators. Thus, to further examine whether native TACC2s can be found complexed with other HATs in vivo, we next performed coimmunoprecipitation experiments with commercial antibodies individually raised against native hGCN5L2, pCAF, p300 and CBP. Figure 3a demonstrates that in the human embryonic kidney cell line 293, native TACC2s coimmunoprecipitates with all these four proteins. We next examined whether a highly specific commercial antibody raised to an internal region of human TACC2s (Lauffart et al., 2003) , which does not overlap the proposed HAT-binding site, could immunoprecipitate the native TACC2-pCAF complex from HEK293 and the breast cancer cell line MCF7. In both cell lines, this antibody immunoprecipitates a TACC2 complex that contained endogenous pCAF (Figure 3b) , further strengthening the conclusion that TACC2s binds to pCAF in human cells.
We have previously demonstrated that overexpression of TACC2s can reduce the in vitro tumorigenic properties of some breast cancer cell lines (Lauffart et al., 2003) , a process that appears to be mediated by the conserved TACC domain (Chen et al., 2000; Still et al., unpublished) . Furthermore, the involvement of HATs in human cancer has now been demonstrated (Borrow et al., 1996; Ida et al., 1997; Sobulo et al., 1997; Chaffanet et al., 1999; Gayther et al., 2000) , and the hGCN5L2 gene has been suggested to be a candidate tumor suppressor in those cases of ovarian and breast cancer that show loss of heterozygosity in chromosome 17q21, without BRCA1 mutations (Tangir et al., 1996; Niederacher et al., 1997) . Therefore, we were particularly interested in determining whether the TACC proteins could interact with hGCN5L2 and pCAF Figure 2 In vitro interaction between hGCN5L2 and the TACC proteins. Top panel: Autoradiograph of 10% SDS polyacrylamide gel with in vitro translated hGCN5L2 construct pulled down with GST-TACC1 aa596-ter (T1), GST-TACC2s (T2) aa2-ter, GST-TACC3 aa116-ter (T3) or GST (G). I: 5% input of in vitro translated hGCN5L2 construct. The bottom two panels represent Coomassie blue stained gels of a pull-down experiment showing loading of GST-TACC proteins and GST. Assays were performed as described in Figure 1 Figure 3 TACC proteins interactions with HATs in cells. (a) HEK293 lysates were immunoprecipitated with goat antibodies to native hGCN5L2, and pCAF, or rabbit polyclonal antibodies to CBP, and p300, or normal species specific IgG, and filters incubated with a-TACC2 antibody. TACC2s is detected in the immunoprecipitates (IPs) of the four HATs, but not in control IgG IPs. (b) pCAF is specifically immunoprecipitated from HEK293 and MCF7 cell lysates by a commercial antibody raised to TACC2. (c) pCAF interacts with TACC2s and TACC3 in breast cancer cells. Cells were immunoprecipitated with mouse a-pCAF or mouse IgG and immunoblotted with a-TACC1, a-TACC2 or a-TACC3 antibody as described in Lauffart et al. (2002) . The a-pCAF antibody specifically immunoprecipitates both the native TACC2s and TACC3 protein in MCF7, MDA-MB-468 and MBA-MB-231, but fails to immunoprecipitate TACC1. WCE: whole-cell extract. Commercial antibodies were obtained from the following companies, and used according to the manufacturers' instructions: anti-TACC2 rabbit polyclonal IgG #07-228 (Upstate Biotechnology, Lake Placid NY, USA), anti-hGCN5 (#sc-6303), anti-pCAF (#sc-6300, sc-13124), anti-p300 (#sc-584) and anti-CBP (#sc-369) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Normal IgG and anti-goat-HRP, anti-rabbit-HRP and anti-mouse-HRP conjugates were also obtained from Santa Cruz Biotechnology. The culture of cell lines, preparation of cell lysates, immunoprecipitation and Western blot analysis were performed as described in Lauffart et al. (2002) expressed in breast cancer cell lines. All of the MDA-MB-231, MDA-MB-468 and MCF7 cell lines expressing TACC2s (Lauffart et al., 2003) also express pCAF (Figure 3c ). However, since these cell lines do not express significant levels of hGCN5L2 (data not shown), our coimmunoprecipation analysis was carried out exclusively using an antibody specific for native pCAF. Consistent with our prediction, both native TACC2s and TACC3 were found in the complex containing endogenous pCAF (Figure 3c ). However, we were unable to detect any interaction between TACC1 and pCAF in any of these cell lines (Figure 3c ), or the immortalized, but not transformed MCF10A breast epithelial cell line (data not shown). Thus, it remains uncertain whether in breast epithelial cells, TACC1 is a preferred binding partner of this HAT.
As stated above, and shown in Figure 4 , TACC2 is distributed throughout the cytoplasm and the nucleus of cells in culture. To further confirm that the pCAF and TACC2 proteins could physically interact in the intact cell, we next determined whether pCAF colocalized with endogenous TACC2 in the breast cancer cell line MCF7. Indirect immunofluorescence microscopy demonstrated that native TACC2 is found in both cytoplasmic and nuclear compartments of interphase MCF7 cells (Figure 4b ). This distribution has been previously observed for TACC2 in other human cell lines (Chen et al., 2000; Gergely et al., 2000) . In these cells, endogenous pCAF is diffusely distributed throughout the nucleus, but is absent from the nucleoli (Figure 4b ). Superimposing the images for the two antibodies reveals that both proteins colocalize throughout the nucleus, but are not found in discrete subnuclear structures. This indicates that both the TACC proteins and the HATs can be physically located and potentially interact in the same subcellular compartment.
As presented above, we have demonstrated that the TACC proteins have the ability to bind in vitro and in cellular systems to the members of the HAT family of transcriptional coactivators. In humans, hGCN5L2 copurifies with the SAGA-related transcriptional adaptor complexes STAGA and TFTC (Martinez et al., 1998) . The homologous protein, pCAF, also coimmunoprecipitates with factors known to regulate the transcriptional activity of promoters (Ogryzko et al., 1998) . In these complexes, the HAT activity of hGCN5L2/pCAF is required for the acetylation of the N-terminal tails of core histones and/or transcription factors, which facilitates the binding of the general transcription machinery, thereby promoting transcription. Thus, the direct interactions of members of the TACC family with the transcription factors ARNT1 (Sadek et al., 2000) and STAT5 (Piekorz et al., 2002) , the oncogene GAS41 (Lauffart et al., 2002 (Lauffart et al., , 2003 , the SWI/SNF core component INI1 (Lauffart et al., 2003) , and now the HAT proteins, further support the notion that the TACC family may represent a novel family of transcriptional accessory or regulatory proteins. Indeed, in vivo, immunohistochemical analysis of cross sections of normal human and mouse tissues clearly show that the major subcellular site of one TACC protein, TACC3, is the nucleus indicating that this may be the site of the major function of this protein in interphase cells (Aitola et al., 2003; Sadek et al., 2003) .
It is also clear that the function of hGCN5L2 and pCAF is not limited to transcription. hGCN5L2/pCAF also interact with pre-mRNA splicing complexes and DNA-damage repair enzymes, suggesting that acetylation by these HATs is of critical importance to a diverse set of nuclear regulatory events (Martinez et al., 2001) . The lack of significant binding of pCAF to TACC1 in breast cancer cell lines may in part be due to a more prominent role of TACC1 in post-transcriptional events, through its interaction with the RNA processing and Figure 4 Colocalization of TACC2s and pCAF endogenous proteins in the nucleus of interphase cells. (a) TACC2 is distributed in both nuclear and cytoplasmic (cyto) extracts of HEK293 cells and MCF7 cells. pCAF is predominantly found in the nucleus. The leakage of pCAF protein into the cytoplasmic fraction of HEK293 cells is probably due to nuclear breakdown during extract preparation. Cytoplasmic and nuclear extracts were prepared as described in Schreiber et al. (1989) . (b) (i) Indirect immunofluorescence of TACC2 detected with fluorescein isothiocyanate (FITC)-conjugated secondary antibody shows distribution in the cytoplasm and nucleus of MCF7 cells; (ii) nuclear localization of pCAF, detected with Texas red-secondary antibody; and (iii) overlay of the previous images reveals colocalization of both proteins in the nucleus. The green and red colors in the superimposed images result in a yellow color. Nuclei were counterstained with DAPI (panel iv). MCF7 cells were prepared as previously described (Lauffart et al., 2002) . Cells on coverslips were incubated with the a-TACC2 polyclonal antibody (Upstate Biotech) together with the a-pCAF mouse monoclonal antibody (Santa Cruz) for 1 h at room temperature. The coverslips were washed with PBS (3 Â 5 min.) and incubated with a mixture of FITC-anti-rabbit IgG and Texas red-conjugated anti-mouse IgG for 30 min. Finally, the coverslips were washed with PBS (3 Â 5 min), mounted with Vectashield containing DAPI and examined at Â 60 magnification (oil). Secondary antibodies were obtained from Jackson Immunolabs TACC interaction with histone acetyltransferases O Gangisetty et al transport proteins, LSm7 and SmG (Conte et al., 2002; Lauffart et al., 2002) , as opposed to transcriptional regulation. Intriguingly, a post-transcriptional role for the Xenopus TACC protein, maskin, has previously been demonstrated (Stebbins-Boaz et al., 1999) . This protein is involved in the regulation of the specific polyadenylationinduced translation of maternal mRNA during oocyte maturation (Stebbins-Boaz et al., 1999) , suggesting that the vertebrate TACC proteins may be directly involved at multiple steps during the process of gene expression. In summary, the findings presented here, together with those from previous studies, clearly indicate that TACC proteins are a multifunctional family of proteins that not only play a role in the functional aspects of mitotic spindle formation during mitosis but may also perform an assembly or coordination function bringing elements of the chromatin remodeling, transcriptional and post-transcriptional machinery together in the interphase nucleus. Based on the results presented in this manuscript and the growing number of basal transcription components with which the TACC proteins interact, it is tempting to speculate that the interaction of TACC proteins with the SWI/SNF complex and HATs may in part explain the coactivation of hypoxia-induced transcription that has been observed for murine TACC3 (Sadek et al., 2000) . Furthermore, this may suggest that the ability of TACC2s to reduce the malignant properties of some breast carcinomas may in part be due to changes in the activity of TACC2-HAT complexes in the regulation of genes governing cell proliferation and metastasis.
